Basket

  Untick selected:   0
  1. Trastuzumab deruxtekan u pacientok s HER2-low karcinómom prsníka a štúdia DESTINY-Breast04 / spracovala Jana Fabiánová. Farmakoterapia Roč. 13, č. 2 (2023), s. 78 a 80-82
    article

    article


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.